Header Logo

Connection

TIMOTHY LOTZE to Multiple Sclerosis

Back to Details
This is a "connection" page, showing publications TIMOTHY LOTZE has written about Multiple Sclerosis.
TIMOTHY LOTZE
Connection Strength
5.735
Multiple Sclerosis
  1. Lymphocytic hypophysitis associated with pediatric multiple sclerosis. Pediatr Neurol. 2014 Oct; 51(4):580-2.
    View in: PubMed
    Score: 0.364
  2. Case report: "Purely" psychiatric presentation of multiple sclerosis in an adolescent boy. J Am Acad Child Adolesc Psychiatry. 2007 Sep; 46(9):1213-1217.
    View in: PubMed
    Score: 0.227
  3. Study of the Association Between Menarche and Disease Course in Pediatric Multiple Sclerosis. Neurology. 2025 Feb 25; 104(4):e210213.
    View in: PubMed
    Score: 0.190
  4. Distinct plasma lipids predict axonal injury and multiple sclerosis activity. J Neurol Neurosurg Psychiatry. 2025 Jan 16; 96(2):150-157.
    View in: PubMed
    Score: 0.189
  5. Epidemiology and Impact of Social Hardships in Children With Multiple Sclerosis in the United States. Neurology. 2024 Dec 10; 103(11):e209991.
    View in: PubMed
    Score: 0.187
  6. Patient and family views on research priorities and design of clinical trials and research studies in pediatric multiple sclerosis. Mult Scler. 2024 Oct; 30(11-12):1525-1543.
    View in: PubMed
    Score: 0.185
  7. Early Adversity and Socioeconomic Factors in Pediatric Multiple Sclerosis: A Case-Control Study. Neurol Neuroimmunol Neuroinflamm. 2024 Sep; 11(5):e200282.
    View in: PubMed
    Score: 0.184
  8. Association of nutritional intake with clinical and imaging activity in pediatric multiple sclerosis. Mult Scler. 2024 Jul; 30(8):1056-1065.
    View in: PubMed
    Score: 0.182
  9. Gene-environment interactions: Epstein-Barr virus infection and risk of pediatric-onset multiple sclerosis. Mult Scler. 2024 Mar; 30(3):308-315.
    View in: PubMed
    Score: 0.177
  10. Gene-environment interactions and risk of pediatric-onset multiple sclerosis associated with time spent outdoors. Mult Scler Relat Disord. 2024 Feb; 82:105351.
    View in: PubMed
    Score: 0.175
  11. Assessing Needs and Perceptions of Research Participation in Pediatric-Onset Multiple Sclerosis: A Multistakeholder Survey. Pediatr Neurol. 2024 Feb; 151:115-120.
    View in: PubMed
    Score: 0.175
  12. Demographic Features and Clinical Course of Patients With Pediatric-Onset Multiple Sclerosis on Newer Disease-Modifying Treatments. Pediatr Neurol. 2023 Aug; 145:125-131.
    View in: PubMed
    Score: 0.168
  13. Characteristics of pediatric patients with multiple sclerosis and related disorders infected with SARS-CoV-2. Mult Scler. 2023 04; 29(4-5):576-584.
    View in: PubMed
    Score: 0.167
  14. Silent findings: Examination of asymptomatic demyelination in a pediatric US cohort. Mult Scler Relat Disord. 2023 Mar; 71:104573.
    View in: PubMed
    Score: 0.166
  15. Gene-environment interactions increase the risk of paediatric-onset multiple sclerosis associated with household chemical exposures. J Neurol Neurosurg Psychiatry. 2023 07; 94(7):518-525.
    View in: PubMed
    Score: 0.165
  16. MOG and AQP4 Antibodies among Children with Multiple Sclerosis and Controls. Ann Neurol. 2023 02; 93(2):271-284.
    View in: PubMed
    Score: 0.161
  17. A new look at cognitive functioning in pediatric MS. Mult Scler. 2023 01; 29(1):140-149.
    View in: PubMed
    Score: 0.161
  18. Gene-environment interactions increase the risk of pediatric-onset multiple sclerosis associated with ozone pollution. Mult Scler. 2022 08; 28(9):1330-1339.
    View in: PubMed
    Score: 0.153
  19. Familial History of Autoimmune Disorders Among Patients With Pediatric Multiple Sclerosis. Neurol Neuroimmunol Neuroinflamm. 2021 09; 8(5).
    View in: PubMed
    Score: 0.149
  20. Pediatric Multiple Sclerosis Severity Score in a large US cohort. Neurology. 2020 09 29; 95(13):e1844-e1853.
    View in: PubMed
    Score: 0.138
  21. Real-World Effectiveness of Initial Disease-Modifying Therapies in Pediatric Multiple Sclerosis. Ann Neurol. 2020 07; 88(1):42-55.
    View in: PubMed
    Score: 0.137
  22. Cognitive processing speed in pediatric-onset multiple sclerosis: Baseline characteristics of impairment and prediction of decline. Mult Scler. 2020 12; 26(14):1938-1947.
    View in: PubMed
    Score: 0.132
  23. miRNA contributions to pediatric-onset multiple sclerosis inferred from GWAS. Ann Clin Transl Neurol. 2019 Jun; 6(6):1053-1061.
    View in: PubMed
    Score: 0.128
  24. Vitamin D genes influence MS relapses in children. Mult Scler. 2020 07; 26(8):894-901.
    View in: PubMed
    Score: 0.128
  25. Admixture mapping reveals evidence of differential multiple sclerosis risk by genetic ancestry. PLoS Genet. 2019 01; 15(1):e1007808.
    View in: PubMed
    Score: 0.125
  26. Acquisition of Early Developmental Milestones and Need for Special Education Services in Pediatric Multiple Sclerosis. J Child Neurol. 2019 03; 34(3):148-152.
    View in: PubMed
    Score: 0.124
  27. Use of newer disease-modifying therapies in pediatric multiple sclerosis in the US. Neurology. 2018 11 06; 91(19):e1778-e1787.
    View in: PubMed
    Score: 0.123
  28. Early infectious exposures are not associated with increased risk of pediatric-onset multiple sclerosis. Mult Scler Relat Disord. 2018 May; 22:103-107.
    View in: PubMed
    Score: 0.118
  29. Genetic risk factors for pediatric-onset multiple sclerosis. Mult Scler. 2018 12; 24(14):1825-1834.
    View in: PubMed
    Score: 0.114
  30. Examining the contributions of environmental quality to pediatric multiple sclerosis. Mult Scler Relat Disord. 2017 Nov; 18:164-169.
    View in: PubMed
    Score: 0.114
  31. Dietary factors and pediatric multiple sclerosis: A case-control study. Mult Scler. 2018 07; 24(8):1067-1076.
    View in: PubMed
    Score: 0.112
  32. Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MS. Neurology. 2017 Apr 25; 88(17):1623-1629.
    View in: PubMed
    Score: 0.110
  33. Evaluating the association of allergies with multiple sclerosis susceptibility risk and disease activity in a pediatric population. J Neurol Sci. 2017 Apr 15; 375:371-375.
    View in: PubMed
    Score: 0.109
  34. Characteristics of Children and Adolescents With Multiple Sclerosis. Pediatrics. 2016 07; 138(1).
    View in: PubMed
    Score: 0.105
  35. The US Network of Pediatric Multiple Sclerosis Centers: Development, Progress, and Next Steps. J Child Neurol. 2015 Sep; 30(10):1381-7.
    View in: PubMed
    Score: 0.093
  36. Role of MRI in the differentiation of ADEM from MS in children. Neurology. 2009 Mar 17; 72(11):968-73.
    View in: PubMed
    Score: 0.062
  37. MRI in the diagnosis of pediatric multiple sclerosis. Neurology. 2009 Mar 17; 72(11):961-7.
    View in: PubMed
    Score: 0.062
  38. Association Between Sun Exposure and Risk of Relapse in Pediatric-Onset Multiple Sclerosis. Neurol Neuroimmunol Neuroinflamm. 2025 Mar; 12(2):e200375.
    View in: PubMed
    Score: 0.048
  39. Clinical and magnetic resonance imaging outcomes in pediatric-onset MS patients on fingolimod and ocrelizumab. Mult Scler Relat Disord. 2024 Jul; 87:105647.
    View in: PubMed
    Score: 0.045
  40. Association of Rituximab Use With Adverse Events in Children, Adolescents, and Young Adults. JAMA Netw Open. 2021 02 01; 4(2):e2036321.
    View in: PubMed
    Score: 0.036
  41. Impact of an electronic monitoring device and behavioral feedback on adherence to multiple sclerosis therapies in youth: results of a randomized trial. Qual Life Res. 2017 09; 26(9):2333-2349.
    View in: PubMed
    Score: 0.028
  42. Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report. Neurology. 2016 Jan 19; 86(3):245-52.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.